Primary hyperparathyroidism (PHPT) occurring during pregnancy represents a rare and clinically significant scenario. Because the condition affects both the patient and the developing pregnancy, management decisions require careful, case-by-case evaluation.
PHPT in pregnancy is a rare event, and its true incidence is not precisely known. The pregnant patient requires assessment that accounts for the physiological changes of pregnancy alongside the biochemical and clinical features of hyperparathyroidism.
In mild cases, the initial approach centres on maintaining adequate hydration — the full structured regimen, including monitoring parameters and decision points, is available via the protocol.
PHPT in pregnancy is a rare event, but the actual incidence of PHPT in pregnancy is not known.
Mild cases should be managed with hydration and monitoring of calcium levels.
DOI: 10.1002/jbmr.4677
View source ↗